Article ID Journal Published Year Pages File Type
3002278 Nutrition, Metabolism and Cardiovascular Diseases 2013 7 Pages PDF
Abstract
The enthusiastic reports of the nonhematopoietic cytoprotective potential of EPO and its derivatives in the cardiovascular system have not yet been confirmed in placebo-controlled clinical trials.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
Erythropoietin and the vascular wall: The controversy continues
Authors
, ,